N-Ethylhexedrone was patented with the German pharmaceutical company Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1]The toxicity and lengthy-expression wellness effects of leisure N-ethylhexedrone use do not appear to have been researched in any sci